Inventor · disambiguated record
Brett Ullman
Also filed as: ULLMAN BRETT · ULLMAN BRETT R
26 granted patents·22 pending applications·285 citations·filing 1998–2024
96Inventor score
Top patents by PatentIndex Score
48 records- 0195US10479797B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2019·Granted Nov 19, 2019·9 cites·30 claims
- 0295US9732039B2Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Granted Aug 15, 2017·17 cites·13 claims
- 0395US9567327B2Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoXIONG YIFENG·Filed 2008·Granted Feb 14, 2017·57 cites·38 claims
- 0494US8580841B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersJONES ROBERT M·Filed 2009·Granted Nov 12, 2013·21 cites·51 claims
- 0593US9126932B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2013·Granted Sep 8, 2015·17 cites·61 claims
- 0692US9522133B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2015·Granted Dec 20, 2016·9 cites·42 claims
- 0791US10927123B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2020·Granted Feb 23, 2021·2 cites·6 claims
- 0891US10662200B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2019·Granted May 26, 2020·3 cites·24 claims
- 0991US9434692B2Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoXIONG YIFENG·Filed 2007·Granted Sep 6, 2016·18 cites·15 claims
- 1089US11945827B2Rapafucin derivative compounds and methods of use thereofUNIV JOHNS HOPKINS·Filed 2021·Granted Apr 2, 2024·2 cites·4 claims
- 1189US9012478B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2013·Granted Apr 21, 2015·4 cites·47 claims
- 1289US6242422B1(Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteasesIDUN PHARMACUETICALS INC·Filed 1998·Granted Jun 5, 2001·100 cites·36 claims
- 1389US2025074874A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2024·Application pending·0 cites
- 1488US9663500B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Granted May 30, 2017·3 cites·13 claims
- 1586US11560386B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2020·Granted Jan 24, 2023·1 cites·19 claims
- 1686US11339172B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related theretoARENA PHARM INC·Filed 2018·Granted May 24, 2022·3 cites·26 claims
- 1785US11098034B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Granted Aug 24, 2021·1 cites·4 claims
- 1885US10058549B2Imidazo[1,2-α]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Aug 28, 2018·4 cites·12 claims
- 1983US8940891B2Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2009·Granted Jan 27, 2015·6 cites·44 claims
- 2082US10689372B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2018·Granted Jun 23, 2020·1 cites·21 claims
- 2182US10214518B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Feb 26, 2019·2 cites·15 claims
- 2281US11066416B2Rapafucin derivative compounds and methods of use thereofUNIV JOHNS HOPKINS·Filed 2019·Granted Jul 20, 2021·2 cites·8 claims
- 2381US2023257349A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2022·Application pending·0 cites
- 2477US10793529B2Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulatorsARENA PHARM INC·Filed 2018·Granted Oct 6, 2020·1 cites·19 claims
- 2574US10138210B2Substituted pyridazines as prostacyclin receptor modulatorsARENA PHARM INC·Filed 2016·Granted Nov 27, 2018·1 cites·33 claims
- 2674US2021380537A1Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2021·Application pending·0 cites
- 2772US2020407316A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2020·Application pending·0 cites
- 2871US2011224262A1Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2009·Application pending·0 cites
- 2970US11987588B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related theretoARENA PHARM INC·Filed 2022·Granted May 21, 2024·0 cites·22 claims
- 3069US2020385357A1Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulatorsARENA PHARM INC·Filed 2020·Application pending·0 cites
- 3168US2021128552A1Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Application pending·0 cites
- 3267US2019135752A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2018·Application pending·0 cites
- 3366US2019284200A1Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2017·Application pending·0 cites
- 3466US2020048205A1Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2019·Application pending·0 cites
- 3564US10351531B2Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Jul 16, 2019·0 cites·22 claims
- 3662US2017217885A1SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2016·Application pending·0 cites
- 3761US2015191454A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2014·Application pending·0 cites
- 3859US2013217700A1Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoXIONG YIFENG·Filed 2012·Application pending·0 cites
- 3959US2019142826A1Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoXIONG YIFENG·Filed 2018·Application pending·0 cites
- 4057US7157430B2(Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted Jan 2, 2007·1 cites·2 claims
- 4157US2021094933A1Rapafucin derivative compounds and methods of use thereofUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 4257US2023000996A1Rapafucin derivative compounds and methods of use thereofUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 4349US2010292233A1Dihydro-1h-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives which act as s1p1 agonistsARENA PHARM INC·Filed 2009·Application pending·0 cites
- 4449US2010273806A1Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2008·Application pending·0 cites
- 4547US2022372014A1Neuroprotective compounds and methods of use thereofUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 4645US2002091089A1(Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteasesFiled 2001·Application pending·0 cites
- 4743US2003232788A1(Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 4838US2010190688A1Tetrapeptide analogsCHAO BIN·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →